Results 61 to 70 of about 23,073,058 (182)

Pharmacoeconomic considerations in the treatment of breast cancer

open access: yes, 2010
Athanasios Pallis1, Vasiliki Tsiantou2, Efi Simou3, Nikos Maniadakis41Department of Medical Oncology, University General Hospital of Heraklion, Crete; 2Department of Health Economics, 3Department of Epidemiology and Biostatistics; 4Department of Health ...
Efi Simou   +3 more
core  

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION [PDF]

open access: yes, 2016
Objective. Pharmacoeconomic analysis of the use of combinations of antihypertensive drugs were olmesartan/lercanidipine and zofenopril/lercanidipine in patients with essential hypertension II-III stage.Materials and methods.
M. M. Petrova   +2 more
core   +1 more source

METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES

open access: yesФармакоэкономика, 2015
pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment.
R. I. Yagudina, I. V. Sorokovikov
doaj  

Economic Burden and Treatment Patterns Among Patients Diagnosed With Vitiligo in Japan: An Observational Retrospective Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Vitiligo, a common and chronic depigmentation disorder, significantly impacts patients' quality of life and exerts a substantial economic burden. The deleterious impact of vitiligo can be exacerbated by comorbid conditions, including psychiatric and autoimmune conditions.
Naoki Oiso   +9 more
wiley   +1 more source

PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING

open access: yesФармакоэкономика, 2015
A properly conducted pharmacoeconomic study and its results are a new element in the body of evidence for drugs recently introduced into clinical practice.
M. V. Protsenko, N. I. Koroleva
doaj  

Codeines Medicine: ABC/VED Analysis, Effectiveness and Rationality of Application

open access: yesAnnals of Mechnikov's Institute
Introduction. Pharmacoeconomic analysis is an important tool for evaluating the rational use of medicines, especially in conditions of limited funding. Codeine medicines are used to treat pain and cough, but their cost and share of total medicines costs ...
Oleksandr Nevzghoda   +3 more
doaj   +1 more source

Oral Semaglutide in Routine Clinical Practice: 24‐Month Real‐World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Real‐world long‐term data on oral semaglutide are limited. We evaluated its 24‐month effectiveness, persistence, and safety in adults with type 2 diabetes (T2D). Materials and Methods This retrospective real‐world study included 232 adults with T2D initiating oral semaglutide at an Italian diabetes clinic.
Maria Pompea Antonia Baldassarre   +6 more
wiley   +1 more source

Pharmacoeconomic analysis of drugs used in traumatology [PDF]

open access: yes, 2018
Drugs used in traumatology are analyzed in scientific studies. The process of treating patients was in-vestigated, types of diseases and associated conditions were analyzed.
Suyunov, N. D   +2 more
core  

Pharmacoeconomic research

open access: yes, 2003
Efficacy and safety are crucial considerations in judging drugs, for example, whether or not to include them in a local formulary. More and more, pharmacoeconomic aspects are becoming of additional importance.
Postma, Maarten; id_orcid   +1 more
core   +1 more source

Medication Adherence Interventions for Older Adults: A National Mixed‐Methods Study of Implementation Across Italian Healthcare Settings

open access: yesJournal of the American Geriatrics Society, EarlyView.
Implementing medication adherence interventions for older adults across healthcare‐system levels. ABSTRACT Background Medication non‐adherence is common among older adults and represents a major challenge for healthcare systems. Effective interventions are needed to support adherence and inform quality‐improvement efforts.
Sara Mucherino   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy